1326 - 1350 of 8823 Results
Title
Year
-
OPENTitle: Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and OpportunitiesJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page: 615461End Page: 615461Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.615461Best OA location URL: https://doi.org/10.3389/fcell.2020.615461Citation Count: 124
-
OPENTitle: Nucleic Acid–Based Therapeutics for Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 16Issue #: 2Start Page: 287End Page: 298Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-019-00714-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-019-00714-7.pdfCitation Count: 52
- Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review2019OPENTitle: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 129End Page: 139Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12874Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7011644Citation Count: 43
-
OPENTitle: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New ApproachesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 29Issue #: 12Start Page: 3937End Page: 3966Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7234797Citation Count: 53
-
OPENTitle: The complex role of inflammation and gliotransmitters in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 176Issue #:Start Page: 105940End Page: 105940Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105940Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105940Citation Count: 38
-
RESTRICTEDTitle: Therapeutic approaches to cholinergic deficiency in Lewy body diseasesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 1Start Page: 41End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1676152Citation Count: 11
-
OPENTitle: Clinical Chronobiology: Circadian Rhythms in Health and DiseaseJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 45Issue #: 03Start Page: 317End Page: 332Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1055/a-2538-3259Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12323393Citation Count: 2
-
OPENTitle: Targeting the proteostasis network in Huntington’s diseaseJournal Name: Ageing Research ReviewsPublisher: Elsevier BVVol: 49Issue #:Start Page: 92End Page: 103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.arr.2018.11.006Best OA location URL: https://doi.org/10.1016/j.arr.2018.11.006Citation Count: 78
-
OPENTitle: A framework for translating tauopathy therapeutics: Drug discovery to clinical trialsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 11Start Page: 8129End Page: 8152Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.14250Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.14250Citation Count: 12
-
OPENTitle: Adapting the proteostasis capacity to sustain brain healthspanJournal Name: CellPublisher: Elsevier BVVol: 184Issue #: 6Start Page: 1545End Page: 1560Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2021.02.007Best OA location URL: http://www.cell.com/article/S0092867421001574/pdfCitation Count: 108
-
RESTRICTEDTitle: Volitional Control of Brain Motor Activity and Its Therapeutic PotentialJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 8Start Page: 1187End Page: 1196Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.007Citation Count: 14
-
OPENTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 68
-
OPENTitle: Body-first Parkinson’s disease and variant Creutzfeldt–Jakob disease – similar or different?Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 164Issue #:Start Page: 105625End Page: 105625Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105625Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105625Citation Count: 7
-
OPENTitle: Impulse control disorders and related behaviors in Parkinson's disease: risk factors, clinical and genetic aspects, and managementJournal Name: Current Opinion in NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 34Issue #: 4Start Page: 547End Page: 555Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wco.0000000000000955Best OA location URL: https://hal.science/hal-03298526Citation Count: 19
-
OPENTitle: The Impact of COVID‐19 on Access to Parkinson's Disease MedicationJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2129End Page: 2133Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28293Best OA location URL: https://doi.org/10.1002/mds.28293Citation Count: 46
-
RESTRICTEDTitle: Proteomics of human cerebrospinal fluid – the good, the bad, and the uglyJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 1Issue #: 8Start Page: 805End Page: 819Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/prca.200700081Citation Count: 57
-
RESTRICTEDTitle: Management of dystonia in Europe: a survey of the European network for the study of the dystonia syndromesJournal Name: European Journal of NeurologyPublisher: WileyVol: 23Issue #: 4Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12940Citation Count: 10
-
OPENTitle: Alzheimer Research Forum Live Discussion: Mice on Trial? Issues in the Design of Drug StudiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 16Issue #: 1Start Page: 197End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2009-0961Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad00961?id=journal-of-alzheimers-disease%2Fjad00961Citation Count: 1
-
RESTRICTEDTitle: Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neuronsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 42Issue #: 9Start Page: 2699End Page: 2706Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.13066Citation Count: 30
-
OPENTitle: O4‐10‐04: LARGE‐SCALE PROTEOMIC ANALYSIS OF HUMAN PREFRONTAL CORTEX IDENTIFIES PROTEINS ASSOCIATED WITH COGNITIVE TRAJECTORY IN ADVANCED AGEJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 15Issue #: 7S_Part_24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2019.06.4797Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.06.4797Citation Count: 0
- Mining the neuroimaging literature using the SumsDB database: stereotaxic coordinates and more!2009OPENTitle: Mining the neuroimaging literature using the SumsDB database: stereotaxic coordinates and more!Journal Name: Frontiers in NeuroinformaticsPublisher: Frontiers Media SAVol: 3Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/conf.neuro.11.2009.08.021Best OA location URL: https://doi.org/10.3389/conf.neuro.11.2009.08.021Citation Count: 3
-
OPENTitle: Algorithmic Complexity of EEG for Prognosis of Neurodegeneration in Idiopathic Rapid Eye Movement Behavior Disorder (RBD)Journal Name: Annals of Biomedical EngineeringPublisher: Springer Science and Business Media LLCVol: 47Issue #: 1Start Page: 282End Page: 296Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10439-018-02112-0Best OA location URL: https://zenodo.org/record/3507853Citation Count: 27
-
OPENTitle: Phosphorylation of Ser111 in Rab8a Modulates Rabin8-Dependent Activation by Perturbation of Side Chain Interaction NetworksJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 58Issue #: 33Start Page: 3546End Page: 3554Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.biochem.9b00516Citation Count: 10
- Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model2008OPENTitle: Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease modelJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 105Issue #: 2Start Page: 728End Page: 733Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0711018105Best OA location URL: http://doi.org/10.1073/pnas.0711018105Citation Count: 292
-
OPENTitle: TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasisJournal Name: Cell Death & DifferentiationPublisher: Springer Science and Business Media LLCVol: 19Issue #: 6Start Page: 1013End Page: 1026Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/cdd.2011.189Best OA location URL: https://www.nature.com/articles/cdd2011189.pdfCitation Count: 81